Journal
Article title
Authors
Title variants
Languages of publication
Abstracts
Multidrug resistance-associated protein (MRP1) causes cellular drug resistance in several cancer cell lines. In this paper we show that antisense oligonucleotides decrease MRP1 expression in human leukaemia cells. We investigated biological activity of a series of 12 linear phosphorothioate oligonucleotides, complementary to several regions of MRP1 mRNA. The oligonucleotides were administered to leukaemia HL60/ADR cells overexpressing MRP1 protein. Then, the level of MRP1 mRNA was determined by means of semiquantitative RT-PCR and the protein level by reaction with specific monoclonal antibodies. Some of the investigated antisense oligonucleotides decrease the expression level of the MRP1 protein by 46% and its mRNA level by 76%.
Journal
Year
Volume
Issue
Pages
1183-1188
Physical description
Dates
published
2000
received
2000-04-20
revised
2000-06-14
accepted
2000-09-20
Contributors
author
- Polish Academy of Sciences, Centre of Molecular and Macromolecular Studies, Department of Bioorganic Chemistry, Łódź, Poland
author
- Polish Academy of Sciences, Centre of Molecular and Macromolecular Studies, Department of Bioorganic Chemistry, Łódź, Poland
author
- Polish Academy of Sciences, Centre of Molecular and Macromolecular Studies, Department of Bioorganic Chemistry, Łódź, Poland
author
- Polish Academy of Sciences, Centre of Molecular and Macromolecular Studies, Department of Bioorganic Chemistry, Łódź, Poland
author
- Polish Academy of Sciences, Centre of Molecular and Macromolecular Studies, Department of Bioorganic Chemistry, Łódź, Poland
author
- University of Łódź, Department of Molecular Biophysics, Łódź, Poland
author
- University of Łódź, Department of Molecular Biophysics, Łódź, Poland
References
- 1. Zaman, G.J.R., Flens M.J., Leusden van, M.R., Haas de, M., Mulder, H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J. & Borst, P. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 8822-8826.
- 2. Almquist, K.C., Loe, D.W., Hipfner, D.R., Mackie, J.E., Cole, S.P.C. & Deeley, R.G. (1995) Cancer Res. 55, 102-110.
- 3. Bartosz, G. (1998) Postepy Biochem. 44, 136-151 (in Polish).
- 4. Broxterman, H.J., Lankelma, J. & Pinedo, H.M. (1996) Eur. J. Cancer 32A, 1024-1033.
- 5. Loe, D.W., Deeley, R.G. & Cole, S.P.C. (1998) Cancer Res. 58, 5130-5136.
- 6. Rappa, G., Lorico, A., Flavell, R.A. & Sartorelli, A.C. (1997) Canc. Res. 57, 5232-5237.
- 7. Loe, D.W., Deeley, R.G. & Cole, S.P.C. (1996) Eur. J. Cancer 32A, 945-957.
- 8. Nooter, K., Burger, H. & Stoter, G. (1996) Leuk. Lymphoma 20, 381-387.
- 9. Stewart, A.J., Canitrot, Y., Baracchini, E., Dean, N.M., Deeley, R.G. & Cole, S.P.C. (1996) Biochem. Pharmacol. 51, 461-469.
- 10. Zamecnik, P.C. & Stevenson, M.L. (1978) Proc. Natl. Acad. Sci. U.S.A. 75, 280-294.
- 11. Agrawal, S. & Zhao, Q. (1998) Curr. Opin. Chem. Biol. 2, 519-528.
- 12. Crook, R.M. (1996) Handbook of Experimental Pharmacology: Antisense Research and Application (Crooke, S.T., ed) 131, 103-140, Springer-Verlag, Berlin, Heidelberg, New York.
- 13. Cucco, C. & Calabretta, B. (1996) Cancer Res. 56, 4332-4337.
- 14. Kool, M., de Haas, M., Sheffer, G.L., Scheper, R.J., van Eijk, M.J., Juijn, J.A., Baas, F. & Borst, P. (1997) Cancer Res. 57, 3537-3547.
- 15. Stec, W.J., Zon, G., Egan, W. & Stec, B. (1984) J. Am. Chem. Soc. 106, 6077-6080.
- 16. Stec, W.J., Uznanski, B., Wilk, A., Hirschbein, B.L., Fearon, K.L. & Bergor, B.J. (1993) Tetrahedron Lett. 34, 5317-5320.
- 17. Lowry, J.O.H., Rosebrough, N.J., Farr, R.L. & Randal, R.J. (1951) J. Biol. Chem. 193, 265-275.
- 18. Laemmli, U.A. (1970) Nature 227, 680-683.
- 19. Agrawal, S. (1996) Trends Biotechnol. 14, 376- 387.
- 20. Nicklin, P.L., Craig, S.J. & Philips, J.A. (1998) in Handbook of Experimental Pharmacology: Antisense Research and Application (Crooke, S.T., ed.) 131, 141-168, Springer-Verlag, Berlin, Heidelberg, New York.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv47i4p1183kz